News Releases

Gp40 antigen vaccine elicits immune response against Cryptosporidium parvum in pregnant cows to protect their newborn calves through antibodies in colostrum Combined data represent first efficacious C. parvum maternal vaccine worldwide for any species RAHWAY, N.J., August 24, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, […]

Read more

Biomass estimation unit provides key information about average weight, distribution, and growth trends RAHWAY, N.J., August 21, 2023 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch of FALCON® Biomass, a powerful, always-on biomass estimation unit that provides key information about average weight, distribution, and […]

Read more

First EU-licensed poultry vaccine to prevent development of ILT, IBD and MD without the risk of reversion to virulence of ILT Rahway, N.J., June 12, 2023 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today that the European Commission has approved INNOVAX®-ILT-IBD, a dual-construct HVT vaccine that provides […]

Read more

Multiple studies demonstrate the benefit of needle-free vaccination for the prevention and management of Lawsonia intracellularis Additional novel research includes reproductive health, preventive farm care and herd health management MADISON, N.J., May 24, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & […]

Read more

Novel injectable suspension delivers ongoing efficacy against fleas and ticks for dogs six months and older in a single dose MADISON, N.J., May 1, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that […]

Read more

Portfolio expansion provides dogs broad-spectrum protection against Asian longhorned ticks MADISON, N.J., Jan. 26, 2023 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration’s approval of an expanded indication […]

Read more

Dutch Minister Micky Adriaansens attends official facility opening Facility capacity to meet increased global customer demand for our innovative vaccines BOXMEER, the Netherlands, Jan. 23, 2023 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the opening of a state-of-the-art manufacturing facility in Boxmeer, the Netherlands, for […]

Read more

New smart device provides geolocation and dog behavioral tracking capabilities MADISON, N.J., Oct.  18, 2022 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co, Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. launch of Animo® GPS, an activity and behavior monitor […]

Read more

Through its Afya Program, Merck Animal Health is committed to the United Against Rabies collaboration’s “Zero by 30” rabies elimination goal MADISON, N.J., Sept. 28, 2022 – Merck Animal Health, known as MSD Animal Health outside  the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today on […]

Read more